Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants

Journal of Perinatology

Volumn 19, Issue 8 PART. 1, 1999, Pages 573-577

  Gordon, Phillip ^a,e   Rutledge, Joe ^b   Sawin, Robert ^b   Thomas, Sarabeth ^c   Woodrum, David ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; INDOMETACIN;

ARTICLE; CASE CONTROL STUDY; FEMALE; HUMAN; INTESTINE PERFORATION; LUNG DYSPLASIA; MALE; MEDICAL RECORD; NEWBORN; PATHOLOGY; PNEUMOPERITONEUM; RETROSPECTIVE STUDY; RISK FACTOR; SMALL INTESTINE; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; DEXAMETHASONE; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTESTINAL PERFORATION; INTESTINE, SMALL; MALE; MEDICAL RECORDS; PNEUMOPERITONEUM; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033286039     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200269     Document Type: Article

References (18)

1. Bucheit JQ, Stewert DL Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates. Pediatrics 1994;93:32-6.
2. Novack CM, Waffrin F, SillsJH, Pousti TJ, Warden JM, Cunningham MD. Focal intestinal perforation in the extremely low-birth-weight infant J Perinatol 1994; 14:450-3.
3. Raghuveer G, Speidel B, Marlow N, Porter H. Focal intestinal perforation in preterm infants is an emerging disease. Acta Paediatr 1996;85:237-9.
4. Loyd JR. The etiology of gastrointestinal perforations in the newborn. J Pediatr Surg 1969;4:77.
5. McCarthy DW, Qualman S, Besner GE. Absent intestinal musculature: anatomic evidence of an embryonic origin of the lesion. J Pediatr Surg 1994;29:1476-8.
6. Liwin A, Avidor I, Schujman E, et al. Neonatal intestinal perforation caused by congenital defects of the intestinal musculature. Am J Clin Pathol 1984;81: 77-80.
7. Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforation after enterai administration of indomethacin in premature infants. J Pediatr 1985;106: 277-81.
8. Kuhl G, Wille L, Bolkonius M, Seyberth HW. Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr 1985;143: 213-6.
9. McDonnell M, Evans N. Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists. J Paediatr Child Health 1995;31:152-4.
10. Ng PC, Fok TF, So KW, Wong W, Yip PKF. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia. Pediatr Surg Int 1997;12:211-2.
11. Adderson EE, Pappin A, Pavia AT. Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg 1998;33:1463-7.
12. Nygard G, Anthony A, Piasecki C, et al. Acute indomethacin-induced injury in the rat: early morphological and biochemical changes. Gastroenterology 1994;106: 567-75.
13. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Vascular anatomy defines sites of indomethacin-induced jejunal ulceration along the mesenteric margin. Gut 1997;41:763-70.
14. Walsh MJ, Leleiko NS, Sterling KM Jr. Regulation of types I, III, and IV procollagen mRNA synthesis in glucocorticoid-mediated intestinal development. J Biol Chem 1987;262:10814-8.
15. Isreal EJ, Schiffrin EJ, Carter EA, Freiberg E, Walker WA Prevention of necrotizing enterocolitis in the rat with prenatal cortisone. Gastroenterology 1990;99: 1333-8.
16. Halac E, HalacJ, Begue EF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990;117: 132-8.
17. Graham MF, Willey A, Zhu YN, Yager DR, Sugerman HJ, Diegelmann RF. Corti-costeroids repress the interleukin 1β-induced secretion of collagenase in human intestinal smooth muscle cells. Gastroenterology 1997;113:1924-9.
18. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988;113:364-7.